March 28, 2014 – This is a press release by the FDA (announcement relayed without modification): The U.S. Food and Drug Administration today approved Alprolix, Coagulation Factor IX (Recombinant), Fc Fusion Protein, for use in adults and children who have Hemophilia B. …

FDA approves first long-acting recombinant coagulation Factor IX concentrate for patients with Hemophilia B Read more »